You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR METFORMIN HYDROCHLORIDE; SITAGLIPTIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for METFORMIN HYDROCHLORIDE; SITAGLIPTIN

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00103857 ↗	MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2005-03-17	The purpose of this study is to determine the safety and effectiveness of an investigational drug in patients with Type 2 Diabetes Mellitus (T2DM) (a specific type of diabetes).
NCT00337610 ↗	Sitagliptin Metformin Add-on Study in Patients With Type 2 Diabetes Mellitus	Completed	Merck Sharp & Dohme Corp.	Phase 3	2006-06-01	A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic (blood sugar) control on metformin therapy.
NCT00350779 ↗	Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2006-06-12	A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on metformin/peroxisome proliferator-activated receptor gamma (PPARg) agonist combination therapy.
NCT00395343 ↗	Sitagliptin Added-on to Insulin Study (0431-051)	Completed	Merck Sharp & Dohme Corp.	Phase 3	2006-12-11	A clinical study to determine the safety and efficacy of sitagliptin in patients with Type 2 Diabetes Mellitus who have inadequate glycemic control on insulin or insulin/metformin combination therapy.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for METFORMIN HYDROCHLORIDE; SITAGLIPTIN

Condition Name

Chart
Table

Condition Name for METFORMIN HYDROCHLORIDE; SITAGLIPTIN
Intervention	Trials
Type 2 Diabetes Mellitus	64
Diabetes Mellitus, Type 2	48
Type 2 Diabetes	34
Diabetes	13
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for METFORMIN HYDROCHLORIDE; SITAGLIPTIN
Intervention	Trials
Diabetes Mellitus, Type 2	149
Diabetes Mellitus	146
Fatty Liver	4
Polycystic Ovary Syndrome	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for METFORMIN HYDROCHLORIDE; SITAGLIPTIN

Trials by Country

Map
Table

Trials by Country for METFORMIN HYDROCHLORIDE; SITAGLIPTIN
Location	Trials
United States	695
China	58
Canada	55
Mexico	48
India	47
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for METFORMIN HYDROCHLORIDE; SITAGLIPTIN
Location	Trials
Texas	39
California	39
Florida	36
Ohio	29
North Carolina	26
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for METFORMIN HYDROCHLORIDE; SITAGLIPTIN

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for METFORMIN HYDROCHLORIDE; SITAGLIPTIN
Clinical Trial Phase	Trials
Phase 4	57
Phase 3	68
Phase 2/Phase 3	4
[disabled in preview]	20
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for METFORMIN HYDROCHLORIDE; SITAGLIPTIN
Clinical Trial Phase	Trials
Completed	150
Unknown status	12
Recruiting	9
[disabled in preview]	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for METFORMIN HYDROCHLORIDE; SITAGLIPTIN

Sponsor Name

Chart
Table

Sponsor Name for METFORMIN HYDROCHLORIDE; SITAGLIPTIN
Sponsor	Trials
Merck Sharp & Dohme Corp.	61
Novo Nordisk A/S	10
GlaxoSmithKline	7
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for METFORMIN HYDROCHLORIDE; SITAGLIPTIN
Sponsor	Trials
Industry	153
Other	87
NIH	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.